MIMETOGEN PHARMACEUTICALS
Mimetogen Pharmaceuticals Inc. is a clinical-stage ophthalmology drug development company developing peptidomimetics for dry eye, retinitis pigmentosa, dry AMD and glaucoma.
MIMETOGEN PHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Medical Pharmaceutical
Founded:
2004-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.mimetogen.com
Total Employee:
1+
Status:
Active
Contact:
514-667-5869
Email Addresses:
[email protected]
Total Funding:
3.65 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default LetsEncrypt Euro PHP PHP 7 QUIC FLoC Opt-Out FLoC
Similar Organizations
Akaal Pharma Pty. Ltd.
Akaal Pharma Pty. Ltd. is a clinical-stage drug discovery and development company
CMTx Biotech
CMTx Biotech focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Exelan Pharmaceuticals
Exelan Pharmaceuticals is a privately held sales and marketing company.
Latitude Pharmaceuticals
Latitude Pharmaceuticals is a leading-edge formulation development contract research organization
Plextek Consulting
Plextek Consulting has been supporting its clients with technology development.
Radiant Research
Radiant Research is a comprehensive clinical research and development company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Medwell Capital
Medwell Capital investment in Venture Round - Mimetogen Pharmaceuticals
Schooner Capital
Schooner Capital investment in Venture Round - Mimetogen Pharmaceuticals
Medwell Capital
Medwell Capital investment in Series B - Mimetogen Pharmaceuticals
VIMAC Milestone Medical Fund
VIMAC Milestone Medical Fund investment in Series A - Mimetogen Pharmaceuticals
MSBi Valorisation
MSBi Valorisation investment in Series A - Mimetogen Pharmaceuticals
Inovia Capital
Inovia Capital investment in Venture Round - Mimetogen Pharmaceuticals
Official Site Inspections
http://www.mimetogen.com
- Host name: mtl202.greengeeks.net
- IP address: 184.107.122.225
- Location: Montreal Canada
- Latitude: 45.4579
- Longitude: -73.5493
- Timezone: America/Toronto
- Postal: H3E
More informations about "Mimetogen Pharmaceuticals"
Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals is a late stage clinical biotechnology company focused on developing the use of synthetic neurotrophin mimetics as a novel approach to treating ocular surface …See details»
Mimetogen Pharmaceuticals - Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals corporate overview, management, board, advisors, mimetics technology, R&D, clinical development, corporate communicationsSee details»
Mimetogen Pharmaceuticals - Crunchbase Company Profile
Mimetogen Pharmaceuticals Inc. is a clinical-stage ophthalmology drug development company developing peptidomimetics for dry eye, retinitis pigmentosa, dry AMD and glaucoma. Where …See details»
Mimetogen Pharmaceuticals - Craft
Mimetogen Pharmaceuticals is a clinical-stage biotechnology company focused on the use of peptidomimetics to treat ophthalmic diseases. It develops MIM-D3, a drug compound for the …See details»
Mimetogen Pharmaceuticals - Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals corporate overview, management, board, advisors, mimetics technology, R&D, clinical development, corporate communicationsSee details»
Active Startup: Mimetogen Pharma - McGill University
Oct 10, 2019 · Mimetogen Pharmaceuticals is a clinical stage biotechnology company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases.See details»
Mimetogen Pharmaceuticals Inc. - VentureRadar
"Mimetogen Pharmaceuticals is a clinical stage biotechnology company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases with high …See details»
Mimetogen Pharmaceuticals - Overview, News & Similar …
Mar 31, 2020 · View Mimetogen Pharmaceuticals (www.mimetogen.com) location in Quebec, Canada , revenue, industry and description. Find related and similar companies as well as …See details»
President & CEO at Mimetogen Pharmaceuticals - The Org
Wax was the co-founder and Chief Medical Officer/Executive Vice-President of R&D at PanOptica, Inc., a private biotechnology company specializing in ophthalmic pharmaceuticals, …See details»
Mimetogen Pharmaceuticals - Contacts, Employees, Board …
Mimetogen Pharmaceuticals is a clinical-stage ophthalmology drug development company.See details»
Mimetogen Pharmaceuticals, Inc. | Insights
Mar 20, 2018 · Ocugen Inc. says it is ready to take its combination product OCU310 into Phase III after unveiling top-line Phase II data demonstrating tolerability of the two-drug combo. …See details»
Mimetogen Pharmaceuticals - Mimetogen Pharmaceuticals - Press …
Mar 31, 2020 · Mimetogen Pharmaceuticals corporate overview, management, board, advisors, mimetics technology, R&D, clinical development, corporate communicationsSee details»
Mimetogen Pharmaceuticals Completes Enrollment of MIM-728
Mar 31, 2020 · Mimetogen Pharmaceuticals Inc. (“Mimetogen”), a clinical-stage biopharmaceutical company focused on the development of tavilermide, a first-in-class nerve growth factor (NGF) …See details»
Mimetogen Pharmaceuticals Completes Enrollment of MIM-728 …
Mar 31, 2020 · MONTREAL — Mimetogen Pharmaceuticals Inc. (“Mimetogen”), a clinical-stage biopharmaceutical company focused on the development of tavilermide, a first-in-class nerve …See details»
Mimetogen Pharmaceuticals Completes Enrollment of MIM-728 …
Mar 31, 2020 · The MIM-728 trial is a multicenter, randomized, double-masked, placebo-controlled, parallel-group study comparing the efficacy of 5% tavilermide and 1% tavilermide …See details»
Mimetogen Pharmaceuticals - Research & Technology
Mimetogen develops small molecule drugs that mimic the effects of neurotrophins, proteins that are critical for the survival and differentiation of neurons and also help maintain the health and …See details»
Allergan Enters Into Licensing Agreement with Mimetogen …
Nov 4, 2015 · Mimetogen Pharmaceuticals, Inc. is a private company focused on developing the use of peptidomimetics as a novel approach to treating ophthalmic diseases with high unmet …See details»
Allergan Licenses Mimetogen Dry Eye Treatment for $50M+
Nov 4, 2015 · Allergan said today it will develop and commercialize the Phase III dry eye disease treatment tavilermide (MIM-D3) through an exclusive licensing agreement with Mimetogen …See details»
Mimetogen Pharmaceuticals - Mimetogen pharmaceuticals …
Mar 31, 2020 · Mimetogen Pharmaceuticals Inc. (“Mimetogen”), a clinical-stage biopharmaceutical company focused on the development of tavilermide, a first-in-class nerve growth factor (NGF) …See details»
Mimetogen Pharmaceuticals - Mimetogen Pharmaceuticals …
MONTREAL, Quebec, September 28, 2021 - Mimetogen Pharmaceuticals Inc. (“Mimetogen”), a clinical-stage biopharmaceutical company focused on the development of 5% tavilermide, a …See details»